Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Sexual Health Center

Font Size

CDC: 2 Million in U.S. Have Chlamydia

Rates Highest Among African-Americans, Teens

Screening for Chlamydia and Gonorrhea

CDC currently recommends annual chlamydia screenings for all sexually active women under the age of 26, and annual screenings for older women with risk factors for the STD, such as a new sex partner or multiple partners. Screening is also recommended for all pregnant women.

Routine screening for gonorrhea is also recommended for women with a high risk for infection, such as sex workers and women with new or multiple sex partners.

The findings suggest that current chlamydia and gonorrhea screening recommendations are adequate, assuming they are implemented, Datta says.

"If screening recommendations are properly applied they will be effective, but we know that this isn't happening consistently," she says. "This needs to be a focus of STD prevention."

The prevalence analysis appears in Tuesday's issue of the Annals of Internal Medicine.

Penicillin-Resistant Gonorrhea Down

In a separate study, published in the same issue of the journal, another group of CDC researchers reported that the prevalence of penicillin-resistant gonorrhea appears to be declining, while resistance to antibiotics in the class known as fluoroquinolones is on the rise.

In April of this year the CDC recommended that fluoroquinolones no longer be used to treat the infection because of rising resistance among both heterosexual and gay men.

Now only one class of antibiotics -- cephalosporins -- is recommended for the treatment of gonorrhea.

In a press release, CDC officials noted that the declining treatment options underscored the need for new drugs to treat the infection and for better ways to monitor drug resistance.

  • Do you have questions about STDs? Discuss them with others on WebMD’s STDs: Member to Member message board.

1 | 2

Today on WebMD

Sex Drive Killers Slideshow
How Healthy is Your Sex Life
HPV Vaccine Future
Couple in bed
HIV Myth Facts
STD Overview
Birth control pills
Herpes Vaccine Study
6 Tips For Teens
things your guy wish you knew slideshow
Tense teen couple
Better Sex Exercises